Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1995
08/31/1995WO1995022974A2 Film coated tablet of paracetamol and domperidone
08/31/1995WO1995022963A1 Drug targeting system, method for preparing same and its use
08/31/1995WO1995022962A1 Controlled release composition
08/31/1995WO1995022950A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
08/31/1995DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained
08/31/1995DE4405545A1 Oral vitamin compsn. with improved resorption
08/31/1995CA2184198A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
08/31/1995CA2184176A1 Method for stimulating profileration of colon cells using pomc76-103
08/31/1995CA2184002A1 Method and compositions for increasing the serum half-life of pharmacologically active agents
08/31/1995CA2183766A1 Block copolymers
08/31/1995CA2183535A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
08/31/1995CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995CA2161343A1 Cyclosporin-containing powder composition
08/30/1995EP0669131A1 Aquous concentrated solutions containing argatroban
08/30/1995EP0669129A2 Expandable release controlled medicaments
08/30/1995EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
08/30/1995EP0668931A1 Nucleic acid ligands and methods for producing the same
08/30/1995EP0668875A1 Clot directed anticoagulant, process for making same and methods of use
08/30/1995EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions
08/30/1995EP0668774A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
08/30/1995EP0668759A1 Transdermal delivery of ketorolac
08/30/1995EP0556239B1 Aerosol containing medicaments
08/30/1995EP0542824B1 Method for preparing a bioadhesive galenical and galenical thereby obtained
08/30/1995CN1107367A Stabilized pharmaceutical compositions and stabilizing solvent
08/30/1995CN1107334A Oral medicine for reducing cholesterol
08/29/1995US5446091 Collagen-polymer conjugates containing an ether linkage
08/29/1995US5446090 Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
08/29/1995US5446070 Flexible, finite, bioadhesive, therapeutical agent in solid form
08/29/1995US5446063 Anesthetic compositions
08/29/1995US5446033 Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
08/29/1995US5446025 Formulations and method of the percutaneous administration of leuprolide
08/29/1995US5446023 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
08/29/1995US5445832 Composition of sustained and controlled release of medicamentous peptide substances by converting water soluble peptide into a water insoluble peptide salt
08/29/1995US5445828 Having hydrophobic layer of fatty acids, alcohols, esters, salts, glycerides, waxes, paraffin oil
08/29/1995US5445827 Granules consisting of ibuprofen sodium salt, sodium hydrogen carbonate, polyvinylpyrrolidone, sodium carbonate, citric acid
08/29/1995US5445826 Prolonged-release unit dosage formulation; includes a mineral salt which releases a physiologically-acceptable gas upon ingestion
08/29/1995US5445817 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
08/29/1995US5445813 Stable microbubble suspensions as enhancement agents for ultrasound echography
08/29/1995US5445812 Angiographic adjuvant
08/29/1995US5445811 Organ specific emulsion
08/29/1995CA1336826C Chimeric antibody with specificity to human b cell surface antigen
08/29/1995CA1336819C Orally administrable ibuprofen compositions
08/24/1995WO1995022618A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995WO1995022617A1 Host-vector system for use in gene therapy
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022351A1 Composition for topical application
08/24/1995WO1995022347A1 Pharmaceutical preparation containing plasminogen activators
08/24/1995WO1995022343A1 Cyclosporin-containing emulsion composition
08/24/1995WO1995022335A1 Acidified nitrite as an antimicrobial agent
08/24/1995WO1995022333A1 Process for producing a sterile prednisolone gel
08/24/1995WO1995022331A1 Aqueous indolocarbazole solutions
08/24/1995WO1995022325A1 Compositions containing micronized nebivolol
08/24/1995WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems
08/24/1995WO1995022319A1 Process for preparing fine particle pharmaceutical formulations
08/24/1995WO1995022318A1 Drugs, vaccines and hormones in polylactide coated microspheres
08/24/1995WO1995022316A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
08/24/1995WO1995022315A1 Liquid ophthalmic sustained release delivery system
08/24/1995WO1995022310A1 Cosmetic compositions
08/24/1995DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids
08/24/1995DE4405426A1 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate A pharmaceutical preparation containing plasminogen activator (t-PA) or derivatives thereof
08/24/1995CA2183667A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/23/1995EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof
08/23/1995EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof
08/23/1995EP0668349A2 Muteins of pancreatic ribonuclease and uses thereof
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0667779A1 Ophthalmic solution and method of use
08/23/1995EP0667774A1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system.
08/23/1995EP0667767A1 Method for the preparation of creams
08/23/1995EP0297109B1 Process for the preparation of a viscosity-stable antacid composition
08/23/1995CN1107069A Natural lipophilic surfactant-yolk phospholipid 6 and preparing method
08/23/1995CN1107042A Inclusion complex
08/23/1995CN1107041A Transmucosal delivery of macromolecular drugs
08/23/1995CN1029541C Nutritional composition and process for its production
08/22/1995US5444150 For use in solid phase peptide synthesis for introducing side chain bromoacetyl group
08/22/1995US5444096 Stable anhydrous topically-active composition and suspending agent therefor
08/22/1995US5444076 Pharmaceutical preparation for topical application
08/22/1995US5444075 Penetration enhancers for transdermal delivery of systemic agents
08/22/1995US5444052 Synergistic mixture with a glycerol ether
08/22/1995US5444041 Convertible microemulsion formulations
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443846 Granulated preparations and method of producing the same
08/22/1995US5443842 Mixed with isopropyl myristate or palmitate and polyethoxy-lated, hydrogenated castor oils
08/22/1995US5443840 Cosmetic and/or pharmaceutical composition containing a dispersion of lipid vesicles, process for the preparation of the said dispersion and dispersion of lipid vesicles
08/22/1995US5443832 Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
08/22/1995US5443829 For enhancing delivery of drugs across mucous membranes of animals
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995US5443824 Soluble in polyethylene glycol having molecular weight range from 200 to 600; widely used in treatment of connective tissue diseases, inflammatory skin, disorder of keratinization, bullous skin disorder, conjunctiva and leprosy
08/22/1995US5443814 X-ray contrast compositions containing iodophenoxyalkanes and cellulose derivatives
08/22/1995US5443727 Thin, self-interlocking, tactic, hydrophilic polyvinyl alcohol enveloping the surfaces, retaining complex geometric configuration
08/22/1995CA1336760C Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021870A1 Method for the preparation of branched cyclomaltooligosaccharides, in particular, branched cyclodextrines
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021845A1 Texaphyrin metal complexes having improved functionalization
08/17/1995WO1995021629A1 Oral delivery of chemically modified proteins
08/17/1995WO1995021628A1 Treatment of antibiotic associated diarrhea
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021622A1 Gel-forming polypeptide derivatives
1 ... 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 ... 1712